Literature DB >> 35015694

Correction: Tumor Burden Limits Bispecific Antibody Efficacy through T-cell Exhaustion Averted by Concurrent Cytotoxic Therapy.

.   

Abstract

Entities:  

Year:  2022        PMID： 35015694      PMCID： PMC9245441          DOI： 10.1158/2643-3230.BCD-21-0176

Source DB:  PubMed          Journal:  Blood Cancer Discov        ISSN： 2643-3230


× No keyword cloud information.
  1 in total

1.  Tumor burden limits bispecific antibody efficacy through T cell exhaustion averted by concurrent cytotoxic therapy.

Authors:  Erin W Meermeier; Seth J Welsh; Meaghen E Sharik; Megan T Du; Victoria M Garbitt; Daniel L Riggs; Chang-Xin Shi; Caleb K Stein; Marco Bergsagel; Bryant Chau; Matthew L Wheeler; Natalie Bezman; Feng Wang; Pavel Strop; P Leif Bergsagel; Marta Chesi
Journal:  Blood Cancer Discov       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.